BETMB: A Dual-Target Compound for Synergistic Suppression of Neuronal Hyperexcitability in Refractory Epilepsy via Concurrent Modulation of Nav Channels and GABAA Receptors.

pentylenetetrazole (BTD-001) - Balance Therap

http://www.ncbi.nlm.nih.gov/pubmed/41574686

Di Zhang; Kai Li; Rui Li; Shengjun Mao; Xin Wang; Yao Nie; Yingying Zhang; Yue Li

Jan 23, 2026